SEC CIK 1297709

Novartis Bioventures Ltd

Reported ownership across 6 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
ALTview stock →8,345,1452018-09-12
ARPOview stock →4,049,8042019-04-26
GRTXview stock →2,467,9612020-06-19
ALRNview stock →2,079,3942019-04-01
BCYCview stock →1,769,6412019-05-28
AKUSview stock →1,181,2582020-06-30

Position History — GRTX

Reported shares owned immediately after each Form 4 transaction, over time.

01,181,0222,362,0453,543,0672019-112020-062020-062020-062020-062020-062020-062020-062020-06

Recent Filings — GRTX

DateActivitySharesPriceOwned After
2020-06-19Open-market sale1,001,312$8.252,467,961
2020-06-18Open-market sale900$9.043,469,273
2020-06-17Open-market sale4,622$9.273,470,173
2020-06-16Open-market sale8,600$9.303,474,795
2020-06-15Open-market sale6,164$9.053,483,395
2020-06-12Open-market sale1,500$9.193,489,559
2020-06-11Open-market sale7,200$9.213,491,059
2020-06-10Open-market sale8,532$9.463,498,259
2020-06-09Open-market sale7,000$9.383,506,791
2020-06-08Open-market sale5,659$9.663,513,791
2020-06-05Open-market sale8,652$9.663,519,450
2020-06-04Open-market sale4,088$9.553,528,102
2020-06-03Open-market sale5,208$9.783,532,190
2020-06-02Open-market sale5,669$9.683,537,398
2019-11-12Conversion (derivative)451,609—0
2019-11-12Conversion (derivative)7,200,000—0
2019-11-12Conversion (derivative)9,000,000—0
2019-11-12Open-market buy250,000$12.003,543,067
2019-11-12Conversion3,293,067—3,293,067

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.